PharmaDiscovery 2006
PharmaDiscovery 2006 will align its aims with the FDA’s recent White Paper “Innovation or Stagnation — Challenge and Opportunity on the Critical Path to New Medical Products,” and will provide a forum for R&D Leaders to assess the impact of innovation within drug discovery and development. The conference is designed to stir debate and discussion in the scientific community and turn discussion into actionable recommendations and tactics that can be applied immediately to drive positive changes in pharma R&D.
www.pharmadiscoveryevent.com